期刊文献+

环孢素A脂质体制备及其体外释药方法学考察 被引量:8

Studies on Preparation and Releasing of Cyclosporin A Liposome in Vitro
下载PDF
导出
摘要 目的:考察环孢素A(cyclosporin A,CsA)脂质体的制备方法、理化性质及其体外释放行为。方法:比较薄膜分散法、逆向蒸发法、乙醇注入法、乙醚注入法所得的环孢素A脂质体(CsA-Lip),并以包封率和载药量为综合指标,正交设计优化CsA-Lip处方工艺;分别采用动态透析法和超速离心法研究CsA-Lip的体外释放行为。结果:乙醇注入法制备CsA-Lip的平均粒径为(80.41±3.12)nm,包封率为(87.09±0.03)%,载药量为(4.98±0.45)%,24 h释放44%。结论:经优化制备的CsA脂质体具有较高的包封率和载药量,并具有缓释作用。 Objective: To study the preparation methods of Cyclosporin A liposome(CsA-Lip) and its characteristics in vitro. Methods: Selecting a proper method from thin film vesicle, reverse-phase evaporation, ethanol-injection and ether-injection technique. The optimized formulation was screened by orthogonal experimental design with entrapment efficiency and loading quality of CsA-Lip as general indexes. The CsA release from drug-loaded liposome was investigated with bag filter and ultracentrifugation in vitro. Results: The particle size, the entrapment efficacy and drug loading of CsA-Lip prepared with ethanol-injection were (80.41 ± 3.12)nm, (87.09 ±0.03)% and (4.98 ± 0.45)% respectively. 44% of total drug was released during the first 24 h. Conclusion: Ethanol-injection was convenient to prepare CsA-Lip which was high in entrapment efficiency and loading and had the advantages of sustained release.
机构地区 苏州大学药学院 [
出处 《抗感染药学》 2008年第4期222-227,共6页 Anti-infection Pharmacy
基金 "江苏省科技厅社会发展项目资助(编号:BS200522) 江苏省高新技术产业发展项目资助(编号:JHB05-46) 江苏省卫生厅招标课题(编号:H200630) 苏州大学医学发展基金资助(编号:EE132503)
关键词 环孢素A 脂质体 体外释放 超速离心 cyclosporin A liposome releasing in vitro ultracentrifugation
  • 相关文献

参考文献15

  • 1[1]Lallemand F,Felt-Byeyens O,Besseghir K,et al.Cyclosporin A delivery to the eye:a pharmaceutical challenge[J].Eur J Pharm Biopharm,2003,56(3):307-318.
  • 2[2]Tjai J F,Webber I R,Back D J.Cyclosporin metabolism by the gastrointestinal mucosa[J].Br J Clin Pharmacol,1991,31(3):344-346.
  • 3[4]Chen HM,Langer R.Oral particulate delivery:status and future trends[J].Adv Drug Deliv Rev,1998,34(2/3):339-350.
  • 4[6]Vemuri S,Rhodes C T.Preparation and characterization of liposomes as therapeutic delivery systems:a review[J].Pharm Acta Hebe,1995,70(2):95-111.
  • 5[8]Danino D,Talmon Y,Zana R.Vesicle-to-micelle transformation in systems containing dimeric surfactants[J].J Colloid Interf Sci,1997,185(1):84-93.
  • 6[9]Castelli F,Puglia C,Sarpietro MG,et al.Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry[J].lnt J Pharm,2005,304(1-2):231-238.
  • 7[10]Ammoury N,Fessi H,Devissaguet JP,et al.In vitro release kinetic pattern of indomethacin from poly(d,lactic) nanocapsules[J].JPharm Sci,1990,79:763.
  • 8[11]Berry MR,Liker MD.Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach[J].J Pharm Biomedical Analysis,2007,45(2):194-200.
  • 9[12]Venkateswarlu V,Manjunath K.Preparation,characterization and in vitro release kinetics of ciozapine solid lipid nanoparticles[J].J Control Release,2004,95(3):627-638.
  • 10[13]Podezeck F.Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT)[J].Int J Pharm,1993,97(I/3):93-100.

同被引文献103

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部